NORTHBROOK, Ill. , April 27, 2015 /PRNewswire/ -- Astellas announced today that CRESEMBA® (isavuconazonium sulfate), the prodrug for... ...http://www.asianhhm.com/pressreleases/astellas-launches-cresemba-isavuconazonium-sulfate-in-the-united-states-for-the-treatment-of-invasive-aspergillosis-and-invasive-mucormycosis
* Apple shares up ahead of results * Amgen's fall drags downs biotech stocks * Celladon nosedives on lead drug's trial failure * Indexes down:... ...http://www.sify.com/finance/us-stocks-wall-st-reverses-course-to-trade-lower-as-health-stocks-drag-news-equity-pe1wErjhhhejb.html
Principal Investigators Perform First Implant of Investigational Medical Device Designed to Expand Applicability of Minimally Invasive Alternative... ...http://newsr.in/n/Press+Releases/754zwtqgn/Medtronic-Starts-Clinical-Study-of-Endurant-Evo-AAA.htm
Reuters 10 minutes ago (Reuters) - Drug developer Celladon Corp said it expected to announce lay-offs and cost cuts as its stock plunged to an... ...https://in.news.yahoo.com/celladon-cut-jobs-gene-therapy-fails-key-trial-142549749--finance.html
(GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that it will begin to manufacture a 12 unit cartridge strength of AFREZZA... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=68413
An additional reason precisely why...